Publications in collaboration with researchers from Universidade da Coruña (4)

2025

  1. HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

    The Lancet Oncology, Vol. 26, Núm. 8, pp. 1100-1112

2024

  1. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

2019

  1. SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 31-45

2017

  1. Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

    PLoS ONE, Vol. 12, Núm. 10